Contrary to popular belief, the marijuana plant is a whole lot more than just a psychoactive drug that “stoners” use to get high.
In raw form, marijuana leaves and buds are actually loaded with a non-psychoactive, antioxidant, anti-inflammatory, and an anti-cancer nutrient compound known as cannabidiol (CBD) that is proving to be a miracle “superfood” capable of preventing and reversing a host of chronic illnesses.
Though you may not have heard much about it, the CBD found in the Cannabis or marijuana plant, which is technically just a herb, is a highly medicinal substance with unique immune-regulating capabilities.
Since the human body already contains a built-in endogenous cannabinoid system, complete with cannabinoid receptors, inputting CBD from marijuana can help normalize the body’s functional systems, including cell communication and proper immune function.
The way CBDs work is that they bridge the gap of neuro transmission in the central nervous system,including in the brain, by providing a two-way system of communication that completes a positive “feedback loop”. As opposed to a one-way transmission, which can promote chronic inflammation of healthy tissue, the unique two-way transmission system engaged by marijuana CBDs mimics the body’s own natural two-way communications system.
One of the best ways to obtain CBDs is to juice raw marijuana leaves and buds. CBD works on receptors and we have endogenous cannabinoids that are very effective at regulating immune functions, nerve functions,bone functions.
The endogenous cannabinoid system acts as a modulator in fine-tuning and if something is deranged biochemically in a person’s body, a phytocannabinoid can bring things back into balance.
While some U.S. states like California and Colorado are beginning to recognize and accept that marijuana has legitimate therapeutic value, the US Federal Government continues to classify marijuana as a Schedule 1 drug with”no currently accepted medical use”.
Cannabidiol CBD is non-psychoactive and can trigger apoptosis in immune cells as well as act as an anti-inflammatory agent.
This opens new avenues with wide-ranging clinical application in the treatment of autoimmune hepatitis as well as other inflammatory disease.
Cannabinoid research has increased tremendously during the last 10 years since the discovery of cannabinoid receptors and the endogenous ligands for these receptors.
The receptors include CB1, predominantly expressed in the brain, and CB2, primarily found on the cells of the immune system.
Unlike THC, which exerts its action by binding to the cannabinoid receptors, CB1 and CB2, CBD does not bind to CB1 receptors and hence has no psychotropic activity.
CB2 selective agonists, devoid of psychotropic effect, can trigger apoptosis in immune cells and act as novel anti-inflammatory/immuno-suppressive agents, for instance in treating hepatitis.
CBD is present in most cannabis preparations (hashish, marijuana,ganja) in higher concentrations than THC.
CBD has no psychotropic (cannabimimetic activity) and does not bind either the brain or the peripheral receptors, CB1 and CB2.
CBD has, however, been observed to have anti-convulsant effects.
CBD has also been effective in animal models predictive of anti-psychotic activity, and has been found to have anti-psychotic effects in the, case of schizophrenia.